Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pao Chin Chiu"'
Autor:
Mei Chyn Chao, Pao Chin Chiu, Siew Lee Wong, Fuu Jen Tsai, Wei De Lin, Ni-Chung Lee, Yu Yuan Ke, Hui Pin Hsiao, Wuh-Liang Hwu, Yin-Hsiu Chien, Chung Hsing Wang, Shao Yin Chu, Beng Huat Lau, Rai Hseng Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 1, Pp 142-147 (2019)
Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by scarce adipose tissue. This disease is distributed worldwide, but little is known about these patients in the Chinese population. Here, we delineate the phenot
Autor:
Yin-Hsiu Chien, Siew Lee Wong, Fuu Jen Tsai, Wen Hui Tsai, Ni-Chung Lee, Chaw Liang Chang, Pao Chin Chiu, Wuh-Liang Hwu, Yen Yin Chou
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Objective Enzyme replacement therapy (ERT), the only approved therapy for infantile-onset Pompe disease (IOPD), had heterogeneous clinical effects due to factors such as severity, age at first treatment, dosage, and dosing regimens. We report the cli
Autor:
Wuh-Liang Hwu, Pao Chin Chiu, Chung Lin Lee, Ju Li Lin, Fuu Jen Tsai, Shio Jean Lin, Tung Ming Chang, Hsiang-Yu Lin, Chih-Kuang Chuang, Dau Ming Niu, Shuan-Pei Lin
Publikováno v:
Diagnostics, Vol 9, Iss 4, p 148 (2019)
Diagnostics
Volume 9
Issue 4
Diagnostics
Volume 9
Issue 4
Background: Children with mucopolysaccharidosis (MPS) generally appear unaffected at birth but may develop multiple clinical manifestations including profound growth impairment as they grow older. Each type of MPS has a variable age at onset and vari
Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease☆
Autor:
Ni-Chung Lee, Wen Hui Tsai, Yin-Hsiu Chien, Pao Chin Chiu, Dwight D. Koeberl, Chaw Liang Chang, Fuu Jen Tsai, Wuh-Liang Hwu
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 11, Iss C, Pp 31-35 (2017)
Molecular Genetics and Metabolism Reports, Vol 11, Iss C, Pp 31-35 (2017)
Background Early initiation of enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase is an effective treatment for patients with infantile-onset Pompe disease (IOPD) but cannot prevent a slow progression of myopathy. Albutero
Clinical characteristics and long-term outcome of Taiwanese children with congenital hyperinsulinism
Publikováno v:
Journal of the Formosan Medical Association, Vol 115, Iss 5, Pp 306-310 (2016)
Background/purposeCongenital hyperinsulinism (CHI) is a rare condition causing severe hypoglycemia in neonates and infants due to dysregulation of insulin secretion. This study aimed to review 20 years' experience in the management of Taiwanese child
Autor:
Chih-Kuang Chuang, Ru-Yi Tu, Wen-Hui Tsai, Yun-Ting Lo, Tung-Ming Chang, Chung-Lin Lee, Chia-Ying Chang, Pao Chin Chiu, Hsiang-Yu Lin, Shuan-Pei Lin, Dau-Ming Niu, Ya-Hui Chang
Publikováno v:
Diagnostics, Vol 9, Iss 4, p 140 (2019)
Diagnostics
Volume 9
Issue 4
Diagnostics
Volume 9
Issue 4
Background: The mucopolysaccharidoses (MPSs) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans (GAGs) and which eventually cause progressive damage to various tissues and organs. We developed a fe
Publikováno v:
Journal of the Chinese Medical Association, Vol 71, Iss 9, Pp 455-460 (2008)
Background Incontinentia pigmenti (IP) is a rare X-linked dominant disorder that involves ectodermal tissues of multiple systems. Previous reports are few in Taiwan. To contribute toward better understanding of IP, we describe and discuss the clinica
Autor:
Pao-Chin Chiu, Kai-Sheng Hsieh, Chu-Chin Chen, Ta-Cheng Huang, Ying-Yao Chen, Mei-Ling Yao, Chu-Chuan Lin, Wen-Hsien Lu
Publikováno v:
Journal of the Chinese Medical Association, Vol 69, Iss 4, Pp 153-156 (2006)
Background: Central venous catheterization is an important procedure for infant patients for a number of different purposes, including nutritional support, surgical operation, hemodynamic monitoring, and multiple lines for critical care medications.